TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis - PubMed (original) (raw)

. 2016 Apr 7;35(14):1785-96.

doi: 10.1038/onc.2015.244. Epub 2015 Aug 3.

F Macari 1 2 3, Y El-Houfi 1 2 3, G Boldina 4 5 6 7, S Khoury-Hanna 1 2 3, J Ollier 1 2 3, L Yazdani 1 2 3, G Zheng 9, I Bièche 10, N Legrand 1 2 3, D Paulet 11, S Durrieu 12, A Byström 8, S Delbecq 13, B Lapeyre 14 15, L Bauchet 16, J Pannequin 1 2 3, F Hollande 1 2 3 17, T Pan 9, M Teichmann 12, S Vagner 4 5 6 7, A David 1 2 3, A Choquet 1 2 3, D Joubert 1 2 3

Affiliations

TRM6/61 connects PKCα with translational control through tRNAi(Met) stabilization: impact on tumorigenesis

F Macari et al. Oncogene. 2016.

Abstract

Accumulating evidence suggests that changes of the protein synthesis machinery alter translation of specific mRNAs and participate in malignant transformation. Here we show that protein kinase C α (PKCα) interacts with TRM61, the catalytic subunit of the TRM6/61 tRNA methyltransferase. The TRM6/61 complex is known to methylate the adenosine 58 of the initiator methionine tRNA (tRNAi(Met)), a nuclear post-transcriptional modification associated with the stabilization of this crucial component of the translation-initiation process. Depletion of TRM6/61 reduced proliferation and increased death of C6 glioma cells, effects that can be partially rescued by overexpression of tRNAi(Met). In contrast, elevated TRM6/61 expression regulated the translation of a subset of mRNAs encoding proteins involved in the tumorigenic process and increased the ability of C6 cells to form colonies in soft agar or spheres when grown in suspension. In TRM6/61/tRNAi(Met)-overexpressing cells, PKCα overexpression decreased tRNAi(Met) expression and both colony- and sphere-forming potentials. A concomitant increase in TRM6/TRM61 mRNA and tRNAi(Met) expression with decreased expression of PKCα mRNA was detected in highly aggressive glioblastoma multiforme as compared with Grade II/III glioblastomas, highlighting the clinical relevance of our findings. Altogether, we suggest that PKCα tightly controls TRM6/61 activity to prevent translation deregulation that would favor neoplastic development.

PubMed Disclaimer

References

    1. Cancer Res. 1992 May 15;52(10):2951-6 - PubMed
    1. Genes Dev. 2004 Jun 1;18(11):1227-40 - PubMed
    1. DNA Cell Biol. 2012 Apr;31(4):434-54 - PubMed
    1. J Biol Chem. 2011 Jun 10;286(23):20688-700 - PubMed
    1. Nucleic Acids Res. 2004 Jan 22;32(2):465-76 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources